New modalities of cancer treatment for NSCLC: focus on immunotherapy

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study2012 · 1,008 citations
2. 2Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer2007 · 118 citations
3. 3Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy2013 · 124 citations
4. 4Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer2005 · 421 citations
5. 5A study of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic tumors.2013 · 191 citations